Vass CM, Boeri M, Poulos C, Turner AJ. Matching and weighting in stated preferences for health care. Journal of choice modelling. 2022 Sep;44. doi: 10.1016/j.jocm.2022.100367
Loria LE, Watson V, Kiso T, Phimister E. Investigating users' preferences for low emission buses: experiences from Europe's largest hydrogen bus fleet. Journal of choice modelling. 2019 Sep;32:100169. doi: 10.1016/j.jocm.2019.05.001
Winfree KB, Ainsworth C, Njue A, Molife C, Lyall M, Jen M-H, Bittoni M, Heyes A, Carbone DP. Defining aggressive disease in patients with advanced NSCLC receiving second-line treatment: a systematic review. Poster presented at the IASLC 19th World Conference on Lung Cancer; September 26, 2018. Toronto, Canada. [abstract] J Thorac Oncol. 2018 Oct; 13(10 (Suppl)):5908. doi: 10.1016/j.jtho.2018.08.1671
Karanth S, Rajan SS, Sharma G, Yamal JM, Morgan RO. Racial-ethnic disparities in end-of-life care quality among lung cancer patients: a SEER-medicare-based study. J Thorac Oncol. 2018 Aug;13(8):1083-93. doi: 10.1016/j.jtho.2018.04.014
Codony-Servat J, Marin-Aguilera M, Visa L, Garcia-Albeniz X, Pineda E, Fernandez PL, Filella X, Gascon P, Mellado B. Nuclear factor-kappa B and interleukin-6 related docetaxel resistance in castration-resistant prostate cancer. Prostate. 2013 Apr;73(5):512-21. doi: 10.1002/pros.22591
Ceilleachair AO, Finn C, Deady S, Carsin AE, Sharp L. Have developments in palliative care services impacted on place of death of colorectal cancer patients in Ireland? A population-based study. Irish J Med Sci. 2011 Mar;180(1):91-6. doi: 10.1007/s11845-010-0607-y
Drummond FJ, Carsin AE, Sharp L, Comber H. Trends in prostate specific antigen testing in Ireland: lessons from a country without guidelines. Irish J Med Sci. 2010 Mar;179(1):43-9. doi: 10.1007/s11845-009-0376-7
Reed (Earnshaw) SR, Reed JH, Stuhldreher TJ. Transaction costs, taxes, and portfolio revision. J Contemp Bus Issue. 1997;5:40-8.